中国临床实用医学
中國臨床實用醫學
중국림상실용의학
CHINA CLINICAL PRACTICAL MEDICINE
2010年
10期
30-31
,共2页
难治性不稳定型心绞痛%地尔硫卓%疗效%安全性
難治性不穩定型心絞痛%地爾硫卓%療效%安全性
난치성불은정형심교통%지이류탁%료효%안전성
Refractory unstable angina%Diltiazem%Efficacy%Security
目的 探讨地尔硫卓对难治性不稳定型心绞痛的疗效和安全性.方法 42例对常规抗心绞痛治疗无效的不稳定型心绞痛患者,给予静脉持续泵入地尔硫卓72 h治疗.严格控制地尔硫卓的剂量.观察治疗前后心绞痛发作次数、发作时ST段压低及血流动力学指标的变化,并注意药物不良反应.结果 静脉滴注地尔硫卓治疗后,心绞痛得到有效控制,总有效率90.5%.与治疗前比较,治疗后的平均心绞痛发作次数减少、每次发作持续时间缩短、发作时ST段压低程度减轻(P<0.05);治疗后血压、心率(P<0.05)和收缩压×心率均明显降低(P<0.01),未发现严重不良反应.结论 地尔硫卓静脉泵入治疗难治性不稳定型心绞痛安全、有效,但需严格控制药物剂量.
目的 探討地爾硫卓對難治性不穩定型心絞痛的療效和安全性.方法 42例對常規抗心絞痛治療無效的不穩定型心絞痛患者,給予靜脈持續泵入地爾硫卓72 h治療.嚴格控製地爾硫卓的劑量.觀察治療前後心絞痛髮作次數、髮作時ST段壓低及血流動力學指標的變化,併註意藥物不良反應.結果 靜脈滴註地爾硫卓治療後,心絞痛得到有效控製,總有效率90.5%.與治療前比較,治療後的平均心絞痛髮作次數減少、每次髮作持續時間縮短、髮作時ST段壓低程度減輕(P<0.05);治療後血壓、心率(P<0.05)和收縮壓×心率均明顯降低(P<0.01),未髮現嚴重不良反應.結論 地爾硫卓靜脈泵入治療難治性不穩定型心絞痛安全、有效,但需嚴格控製藥物劑量.
목적 탐토지이류탁대난치성불은정형심교통적료효화안전성.방법 42례대상규항심교통치료무효적불은정형심교통환자,급여정맥지속빙입지이류탁72 h치료.엄격공제지이류탁적제량.관찰치료전후심교통발작차수、발작시ST단압저급혈류동역학지표적변화,병주의약물불량반응.결과 정맥적주지이류탁치료후,심교통득도유효공제,총유효솔90.5%.여치료전비교,치료후적평균심교통발작차수감소、매차발작지속시간축단、발작시ST단압저정도감경(P<0.05);치료후혈압、심솔(P<0.05)화수축압×심솔균명현강저(P<0.01),미발현엄중불량반응.결론 지이류탁정맥빙입치료난치성불은정형심교통안전、유효,단수엄격공제약물제량.
Objective To investigate the efficacy and safety of diltiazem to refractory unstable angina pectoris.Methods 42 unstable angina patients,who were failed to conventional anti-angina pectoris treatment,were treated with continuous infusion of intravenous diltiazem for 72 hours.Gradual titration of diltiazem was controlled.Angina attack frequency,ST segment depression and changes in blood rheologic indexes were observed before and after treatment.Results The attack of angina was effectively controlled after diltiazem treatment.The total effective rate was 90.1%.The average attack frequency,average attack duration and depression of ST segment were significantly decreased after diltizaem treatment(P < 0.05).The blood pressure,heart rate ( P < 0.05) and the systolic blood pressure × heart rate significantly decreased(P < 0.01) after diltizaem treatment,without serious adverse reactions.Conclusion It was effective and safe to treat refractory unstable angina pectoris with diltizaem intravenous injection,but the dose titration should be strictly controlled.